Equity (Details) - USD ($) $ / shares in Units, $ in Thousands |
6 Months Ended | |||
|---|---|---|---|---|
Jan. 29, 2024 |
Oct. 24, 2023 |
Dec. 31, 2023 |
Jun. 30, 2023 |
|
| Equity [Line Items] | ||||
| Common stock shares issued (in Shares) | 75,435,479 | 72,154,647 | ||
| Aggregate purchasing value | $ 1,000 | |||
| Minimum bid price requirement (in Dollars per share) | $ 1 | |||
| Nasdaq stock market notification, description | In accordance with Nasdaq listing rules, the Company has been afforded 180 calendar days (until April 22, 2024) to regain compliance with the Bid Price Requirement (the “Initial Compliance Period”). To regain compliance, the closing bid price of the Company’s common stock must meet or exceed $1.00 per share for a minimum of ten consecutive business days during this additional 180-day period, all as described in more detail in the Current Report on Form 8-K filed with the SEC on October 27, 2023. If the Company does not regain compliance by April 22, 2024, the Company may be eligible for an additional grace period. To qualify, the Company must, as of the final day of the Initial Compliance Period, meet the applicable market value of publicly held shares requirement for continued listing and all other applicable standards for initial listing on the Capital Market (except the Bid Price Requirement) based on the Company’s most recent public filings and market information and must notify Nasdaq of its intent to cure this deficiency. If the Company meets these requirements, the Nasdaq staff would be expected to grant an additional 180 calendar days for the Company to regain compliance with Bid Price Requirement. | |||
| Market Value Stock Unit Awards [Member] | Minimum [Member] | ||||
| Equity [Line Items] | ||||
| Vesting ranging | 0.00% | |||
| Market Value Stock Unit Awards [Member] | Maximum [Member] | ||||
| Equity [Line Items] | ||||
| Vesting ranging | 200.00% | |||
| Subsequent Event [Member] | ||||
| Equity [Line Items] | ||||
| Public offering shares (in Shares) | 23,000,000 | |||
| Per share (in Dollars per share) | $ 0.5 | |||
| Common stock shares issued (in Shares) | 3,000,000 | |||
| Gross proceeds | $ 11,500 | |||
| underwriting discount and offering expenses | 1,100 | |||
| net proceeds from the offering | 10,400 | |||
| Aggregate purchasing value | $ 1,000 | |||
| Subsequent Event [Member] | Over-Allotment Option [Member] | ||||
| Equity [Line Items] | ||||
| Common stock shares issued (in Shares) | 3,000,000 | |||
| Equity incentive plan [Member] | Common Stock [Member] | ||||
| Equity [Line Items] | ||||
| Aggregate of shares (in Shares) | 260,000 | |||
| Restricted Stock Units (RSUs) [Member] | ||||
| Equity [Line Items] | ||||
| Number of Restricted Stock Unit | $ 1,600 | |||
| Weighted average fair value grant date fair value per share (in Dollars per share) | $ 0.81 | |||
| Market Value Stock Unit Awards [Member] | ||||
| Equity [Line Items] | ||||
| Number of Restricted Stock Unit | $ 550 | |||
| Weighted average fair value grant date fair value per share (in Dollars per share) | $ 1.41 | |||
| Vesting period | 3 years |